Breast Cancer Clinical Trial
— LEVEL UPOfficial title:
LEVEL UP: Leveraging Electronic Videogames for Exercise and Leisure: Understanding Preferences of Breast Cancer Survivors
The purpose of this study is to test an intervention that uses home console video games to encourage increased physical activity among postmenopausal breast cancer survivors.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | January 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 45 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Female - Aged 45 - 75 - Diagnosed with breast cancer within the past 10 years Exclusion Criteria: - Chemotherapy or radiation treatment in the past six months - Surgery in the past six months - Evidence of disease recurrence - Unable to read and understand English - Unable to see a TV screen from several feet away - Unable to find transportation to the study location - No Internet access in the home (only for intervention portion of the study) - Participant is active (60 minutes of moderate-vigorous intensity activity per week or more) - BMI is under 18.5 kg/m2 or over 40 kg/m2 - Participant reports psychological issues that would interfere with study completion. Examples will be provided to illustrate potential psychological issues, such as dementia or schizophrenia. - Inadequate performance on Senior Fitness Test, indicating inability to engage in video game exercise procedures (total score < 9 out of 12) - Report a heart condition, chest pain during periods of activity or rest, loss of consciousness, etc. on the Physical Activity Readiness Questionnaire (PAR-Q), unless cleared by their physician - Unable to walk, jump, and jog as may be required by some games (self-report) - Report current symptoms of alcohol or substance dependence - Plans to move away from the Galveston-Houston area or to be out of town for more than 1 week during the study period - Unwillingness to report drugs taken for comorbidities such as hypertension or diabetes - Stroke, hip fracture, hip or knee replacement, or spinal surgery in the past 6 months - Report a history of orthopedic complications that would prevent optimal participation in the physical activities prescribed (e.g., heel spurs, severe arthritis) - Clinical judgment concerning safety - Currently participating in a physical activity or weight program/research study - Currently pregnant or nursing - No TV is available in the participant's home - Currently on a weight loss diet or has lost more than 5% body weight in the previous 6 months - Current smoker - Game console to be used in the study is already available in the home - Another member of the household is a participant or staff member on this trial |
Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
United States | University of Texas Medical Branch | Galveston | Texas |
Lead Sponsor | Collaborator |
---|---|
The University of Texas Medical Branch, Galveston | National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Number of participants who drop out of the study from baseline to 6 weeks | We will investigate the number of participants who drop out of the intervention group in comparison to similar studies | 6 weeks | No |
Other | Acceptability | We will measure acceptability of the intervention components and tools using validated self-report measures and qualitative interviews/focus groups | 6 weeks | No |
Other | Number of participants who report adverse events | We will inquire about potential adverse events during counseling calls and assessment visits. Discrete events will be summed, and the number of participants with events will be summed. | 6 weeks | Yes |
Other | Adherence | We will use objective measures to investigate adherence to game play protocols (console logs, automatic postings to the console social network, etc.) | 6 weeks | No |
Primary | Change in physical activity from baseline to 6 weeks | Minutes of moderate-vigorous physical activity measured over a 7 day period | 6 weeks | No |
Secondary | Change in physical fitness from baseline to 6 weeks | We will use a six minute walk test to measure fitness | 6 weeks | No |
Secondary | Change in weight from baseline to 6 weeks | Weight will be measured using a calibrated scale | 6 weeks | No |
Secondary | Change in motivation from baseline to 6 weeks | We will measure autonomous motivation (intrinsic, integrated, identified, etc.) specific to physical activity | 6 weeks | No |
Secondary | Change in body function from baseline to 6 weeks | We will use the Senior Fitness Test to measure strength and body function | 6 weeks | No |
Secondary | Change in quality of life from baseline to 6 weeks | We will use the Functional Assessment of Cancer Therapy - Breast measure to quantify quality of life | 6 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |